Diagnosticos da America (BSP:DASA3) Total Operating Expense: R$2,432 Mil (TTM As of Mar. 2026)


BSP:DASA3 Diagnosticos da America SA BSP:DASA3
53 GF Score
Price R$2.70
GF Value R$1.70
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Diagnosticos da America Total Operating Expense?

Diagnosticos da America BSP:DASA3 +3.05% 53 Total Operating Expense is R$2,432 Mil as of Mar. 2026. GuruFocus rates BSP:DASA3 with a GF Score™ of 53/100 and a GF Value™ of R$1.70 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Diagnosticos da America's Total Operating Expense for the three months ended in Mar. 2026 was R$450 Mil. Diagnosticos da America's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was R$2,432 Mil.

Diagnosticos da America Total Operating Expense Related Terms

Diagnosticos da America Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Diagnosticos da America's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diagnosticos da America Total Operating Expense Chart

Diagnosticos da America Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,028.31 2,750.59 2,975.30 3,186.72 2,381.00

Diagnosticos da America Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.69 584.22 499.58 897.95 449.93
BSP:DASA3
53GF Score
Diagnosticos da America SA BSP:DASA3
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diagnosticos da America Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$2,432 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of R$2,432 Mil mean?
Diagnosticos da America (BSP:DASA3) has a Total Operating Expense of R$2,432 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Diagnosticos da America and its competitors.
Is Diagnosticos da America's Total Operating Expense too high?
Diagnosticos da America's current Total Operating Expense is R$2,432 Mil. Overall, Diagnosticos da America has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Diagnosticos da America's Total Operating Expense compare to TMO and DHR?
Diagnosticos da America's Total Operating Expense of R$2,432 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Diagnostics & Research company?
A good Total Operating Expense depends on the Medical Diagnostics & Research industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Diagnosticos da America and its competitors. Diagnosticos da America's current Total Operating Expense is R$2,432 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnosticos da America stock overvalued right now?
Based on GuruFocus' analysis, Diagnosticos da America (BSP:DASA3) is currently considered Significantly Overvalued. The stock's GF Value™ is R$1.70, compared to a current price of R$2.70 — trading 58.8% above its estimated fair value. The current Total Operating Expense is R$2,432 Mil. Diagnosticos da America's overall GF Score™ is 53/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Diagnosticos da America (BSP:DASA3), the current Total Operating Expense is R$2,432 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Diagnosticos da America (BSP:DASA3) Overvalued in 2026?

Based on GuruFocus' analysis, Diagnosticos da America stock appears to be overvalued. The current stock price of R$2.70 is trading 58.8% above its estimated GF Value™ of R$1.70. GuruFocus considers Diagnosticos da America to be Significantly Overvalued.

Key valuation signals for BSP:DASA3:

  • Total Operating Expense: R$2,432 Mil
  • GF Value™: R$1.70 vs. price of R$2.70 (58.8% above fair value)
  • GF Score™: 53/100 with 3 warning signs

No single metric tells the full story. See the BSP:DASA3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Diagnosticos da America Business Description

Address Avenida Jurua, 434, Alphaville, Barueri, SP, BRA, 06455-010
Diagnosticos da America SA operates as a medical diagnostics company in Brazil. The company offers clinical analysis, diagnostic imaging tests, and patient service centers. It has three operating segments. Outpatient care services and care coordination includes Diagnosis and health management, Hospitals and oncology include Medical and hospital services & Foreign operations include Diagnosis. The majority is from the Hospitals and oncology segment. Geographically, it operates in Brazil and South America (Argentina, Uruguay, Chile and Colombia).
53GF Score

Get the complete analysis for BSP:DASA3

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$2.70
Price
R$1.70
GF Value